Following each of their biannual meetings, both the ICH Assembly and the ICH MedDRA Management Board issue press releases to inform stakeholders on decisions taken during their meetings. On occasion, press releases are also issued between meetings.

In addition to being published on the ICH website, press releases are also distributed through ICH’s press network. If your journal or newspaper would like to receive ICH press releases please contact the ICH Secretariat.

11 November 2012

MedDRA Management Board, San Diego, CA, USA, 10-11 November 2012

The Board is pleased to announce that, for the eighth year in a row, there will be no increase in MedDRA subscription rates for 2013.

3 July 2012

ICH Steering Committee, Fukuoka, Japan, 6-7 June 2012

The six official ICH parties have agreed on new principles of governance which better define the roles of regulator and industry parties within ICH. This action will highlight ICH’s longstanding premise that the regulators have...

4 June 2012

MedDRA Management Board, Fukuoka, Japan, 2-3 June 2012

The MSSO provided data on user uptake of the new MedDRA Version Analysis Tool (MVAT). MVAT assists users in understanding the differences between any two versions of MedDRA...

10 November 2011

ICH Steering Committee, Seville, Spain, 9-10 November 2011

Following an extended consultation period, the SC approved a revised ICH S2(R1) Guideline for genotoxicity testing and data interpretation for medicines intended for human use.